| |
Webinar: Accelerating Advances in Cell & Gene Therapy Production |
|
|
While cell and gene therapies continue to revolutionize and help manage rare and previously untreatable genetic diseases, the production processes for advanced therapies have yet to keep pace. Working to advance these therapies, such as viral vectors, autologous and allogeneic cell processes, is a key focus of the industry to spur continued innovation. Join us on Thursday, December 9, at the BPI Europe Digital Week 2021 to hear Catalent's cell and gene therapy expert, Dr. George Buchman, while he discusses the progress in several areas of advanced development and their impact on readiness for large scale manufacturing. |
|
|
Date: Thursday, December 9, 2021 Time: 8am EST Featured Speaker: |
|
|
George Buchman, PhD Vice President, Pre-clinical and Process Development
Catalent Cell & Gene Therapy |
|
|
| |
Podcast: Manufacturing Cell Therapies with an Individualized Mindset |
|
|
Despite an impressive double-digit cell therapy market growth recently, manufacturing cell therapies at scale has proven to be a challenge. This podcast focuses on the specific needs of manufacturing cell therapies at scale. We discuss how Custom Manufacturing Organizations are driving standardization and process efficiencies. |
|
|
| |
Click below for more information on Catalent's Biologics
services. |
|
We're hiring! If you are looking to help bring life-transforming treatments to patients, join us. |
|
|
| |
